Skip to main content
. Author manuscript; available in PMC: 2017 May 22.
Published in final edited form as: Support Care Cancer. 2016 Aug 18;24(12):5059–5068. doi: 10.1007/s00520-016-3373-1

Fig. 2.

Fig. 2

Acute neuropathy symptom scores, segregated by the worst mean maximum acute cycle 1 score [none (0) versus mild (1–3) versus moderate (4–5) versus severe (7–10)] for oxaliplatin acute neuropathy (a); weekly paclitaxel (b); and every 3 weeks of paclitaxel (c). Higher values indicate more severe symptoms. Abreviation: P-APS stands for paclitaxel-acute pain syndrome